Initial response with paradoxical deterioration following bevacizumab for cerebral radiation necrosis

Pediatr Blood Cancer. 2017 May;64(5). doi: 10.1002/pbc.26313. Epub 2016 Nov 2.

Authors

Ronald Tan¹, Antony Michalski¹, Frank Saran², Kshitij Mankad³, Olga Slater¹

Affiliations

¹ Department of Paediatric Oncology, Great Ormond Street Hospital, London, United Kingdom.
² Department of Neuro-Oncology, Royal Marsden Hospital, London, United Kingdom.
³ Department of Neuro-Radiology, Great Ormond Street Hospital, London, United Kingdom.

PMID: 27805303
DOI: 10.1002/pbc.26313

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adolescent
Bevacizumab / administration & dosage*
Brain Neoplasms / therapy*
Dose Fractionation, Radiation*
Female
Humans
Neuroectodermal Tumors, Primitive / therapy*
Radiation Injuries / drug therapy*

Substances

Bevacizumab